JPMorgan Chase & Co. 13D and 13G filings for Atara Biotherapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime | Transaction Date | Type | Company Symbol | Filed By Symbol | Shares Owned % Owned | Shares Vs. Prev Report | View |
| 2023-12-07 2:45 pm Sale | 2023-11-30 | 13G | Atara Biotherapeutics, Inc. ATRA | JPMORGAN CHASE & CO JPM | 88,277 2.100% | -212,146 (-70.62%) | Filing |
| 2023-01-18 1:30 pm Purchase | 2022-12-30 | 13G | Atara Biotherapeutics, Inc. ATRA | JPMORGAN CHASE & CO JPM | 300,423 7.900% | 3,387 (+1.14%) | Filing |
| 2022-01-07 3:41 pm Purchase | 2021-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | JPMORGAN CHASE & CO JPM | 297,036 8.300% | 55,896 (+23.18%) | Filing |
| 2021-01-08 11:43 am Purchase | 2020-12-31 | 13G | Atara Biotherapeutics, Inc. ATRA | JPMORGAN CHASE & CO JPM | 241,140 7.300% | 241,140 (New Position) | Filing |